Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12
- Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM
implants and agree to participate will be included in this study.
- Patients who do not agree to be included in the study.
Type of Study:
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Hydroxyproline will be measured in the AlloMaxTM and adjacent capsule.
Outcome Time Frame:
Kayvan Taghipour-Khiabani, M.D.
University of Nevada School of Medicine
United States: Institutional Review Board
- Breast Cancer
- Breast reconstruction
- Hydroxyproline concentration
- collagen deposition
- Breast Neoplasms
|University of Nevada School of Medicine
||Reno, Nevada 89503